| 28 days PEP | 5 days PEP |
---|---|---|
Total | 218 (100.0)a | 50 (100.0) |
At least one adverse event | 132 (60.6 [54.0–67.1]) | 15 (30.0 [16.8–43.1]) |
Fatigue | 57 (26.1 [20.3–32.0]) | 5 (10.0 [1.4–18.6]) |
Abdominal disorders | Â | Â |
 - Nausea | 55 (25.2 [19.4–31.0]) | 6 (12.0 [2.7–21.3]) |
 - Vomiting | 5 (2.3 [0.3–4.3]) | 4 (8.0 [0.2–15.8]) |
 - Diarrhea | 37 (17.0 [11.9–22.0]) | 1 (2.0 [0–6.0]) |
 - Abdominal pain | 18 (8.3 [4.6–11.9]) | 0 |
 - Dysphagia | 1 (0.5 [0–1.4]) | 0 |
 - Dysgueusia | 1 (0.5 [0–1.4]) | 0 |
Headache | 17 (7.8 [4.2–11.4]) | 3 (6.0 [0–12.8]) |
Vertigo | 5 (2.3 [0.3–4.3]) | 0 |
Insomnia | 3 (1.4 [0–2.9]) | 0 |
Visual trouble | 1 (0.5 [0–1.4]) | 0 |
Arthralgia or myalgia | 2 (0.9 [0–2.2]) | 0 |
Fever sensation | 3 (1.4 [0–2.9]) | 0 |
Rash | 2 (0.9 [0–2.2]) | 0 |
Cytolysis | 3 (1.4 [0–2.9]) | 0 |